Jun 11, 2026 03:18AM
Mar 13, 2026 01:37PM
Feb 18, 2026 06:19AM
Jan 16, 2026 12:01PM
Nov 20, 2025 08:30AM
Nov 17, 2025 08:30AM
Nov 10, 2025 09:31AM Novartis opens radioligand therapy manufacturing facility in California
Oct 27, 2025 06:33AM
Sep 30, 2025 05:23PM
Sep 30, 2025 05:23PM
Sep 30, 2025 04:16PM
Aug 11, 2025 01:20AM
Jul 31, 2025 04:30PM
Jul 31, 2025 04:30PM Novartis twice-yearly* Leqvio® (inclisiran) receives FDA approval for new indication enabling first-line use
Jun 11, 2025 08:30AM
Apr 9, 2025 05:00AM
Mar 27, 2025 08:30AM
Mar 20, 2025 07:40PM
Mar 20, 2025 07:37PM
Feb 18, 2025 09:00AM
Jan 16, 2025 04:07PM US appeals court reinstates pause on generic version of Novartis' Entresto
Dec 11, 2024 09:44AM
Dec 2, 2024 04:14PM
Nov 5, 2024 07:05AM
Oct 28, 2024 04:44PM
Oct 26, 2024 07:50PM
Sep 24, 2024 08:45AM
Sep 20, 2024 09:00AM How Critical Demand for Metastatic Breast Cancer Therapies is Producing a Multi-Billion Dollar Opportunity for Biotechs
Sep 17, 2024 01:00PM
Aug 28, 2024 07:09AM
Aug 7, 2024 02:23PM
Aug 6, 2024 09:00AM
Jul 30, 2024 07:00AM
May 25, 2024 06:00AM
May 7, 2024 07:00AM Arvinas Reports First Quarter 2024 Financial Results and Provides Corporate Update
Apr 30, 2024 10:14AM
Apr 23, 2024 01:58PM
Apr 17, 2024 01:20AM
Apr 15, 2024 02:02PM
Feb 27, 2024 08:05AM
Feb 27, 2024 08:00AM
Feb 25, 2024 02:00PM New England Journal of Medicine publishes Phase III data showing Xolair® (omalizumab) significantly reduced allergic reactions across multiple foods in people with food allergies
Feb 16, 2024 11:20AM
Feb 14, 2024 08:01AM
Feb 14, 2024 08:00AM
Feb 5, 2024 05:17PM
Feb 5, 2024 04:49PM
Feb 5, 2024 11:47AM
Jan 5, 2024 09:24AM Novartis (NVS) Expands Production of Pluvicto
Jan 5, 2024 09:23AM

322,882 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All